These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10937732)

  • 21. Design and synthesis of novel series of 5-HT6 receptor ligands having indole, a central aromatic core and 1-amino-4 methyl piperazine as a positive ionizable group.
    Hayat F; Cho S; Rhim H; Indu Viswanath AN; Pae AN; Lee JY; Choo DJ; Choo HY
    Bioorg Med Chem; 2013 Sep; 21(17):5573-82. PubMed ID: 23810425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1-[2-[(Heteroarylmethoxy)aryl]carbamoyl]indolines are selective and orally active 5-HT2C receptor inverse agonists.
    Bromidge SM; Davies S; Duckworth DM; Forbes IT; Jones GE; Jones J; King FD; Blackburn TP; Holland V; Kennett GA; Lightowler S; Middlemiss DN; Riley GJ; Trail B; Wood MD
    Bioorg Med Chem Lett; 2000 Aug; 10(16):1867-70. PubMed ID: 10969987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and pharmacological characteristics of novel (Z)-3-arylidene-indolin-2(1H)-ones: preliminary results.
    Mokrosz MJ; Charakchieva-Minol S; Kozioł A; Kłodzińska A; Chojnacka-Wójcik E
    Pol J Pharmacol; 2000; 52(1):47-50. PubMed ID: 10949120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of the 5-HT6 receptor on acetylcholine release in the cortex: pharmacological characterization of 4-(2-bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine, a potent and selective 5-HT6 receptor antagonist.
    Riemer C; Borroni E; Levet-Trafit B; Martin JR; Poli S; Porter RH; Bös M
    J Med Chem; 2003 Mar; 46(7):1273-6. PubMed ID: 12646038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indole-3-piperazinyl derivatives: novel chemical class of 5-HT(6) receptor antagonists.
    Nirogi RV; Deshpande AD; Kambhampati R; Badange RK; Kota L; Daulatabad AV; Shinde AK; Ahmad I; Kandikere V; Jayarajan P; Dubey PK
    Bioorg Med Chem Lett; 2011 Jan; 21(1):346-9. PubMed ID: 21134749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of 3-aryl-3-methyl-1H-quinoline-2,4-diones as a new class of selective 5-HT6 receptor antagonists.
    Seong CM; Park WK; Park CM; Kong JY; Park NS
    Bioorg Med Chem Lett; 2008 Jan; 18(2):738-43. PubMed ID: 18053713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective, centrally acting serotonin 5-HT2 antagonists. 2. Substituted 3-(4-fluorophenyl)-1H-indoles.
    Andersen K; Perregaard J; Arnt J; Nielsen JB; Begtrup M
    J Med Chem; 1992 Dec; 35(26):4823-31. PubMed ID: 1336054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a potent and selective 5-HT(6) antagonist: one-step synthesis of (E)-3-(benzenesulfonyl)-2- (methylsulfanyl)pyrido[1,2-a]pyrimidin-4-ylidenamine from 2-(benzenesulfonyl)-3,3-bis(methylsulfanyl)acrylonitrile.
    Wu YJ; He H; Hu S; Huang Y; Scola PM; Grant-Young K; Bertekap RL; Wu D; Gao Q; Li Y; Klakouski C; Westphal RS
    J Med Chem; 2003 Nov; 46(23):4834-7. PubMed ID: 14584934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and SAR of 3- and 4-substituted quinolin-2-ones: discovery of mixed 5-HT(1B)/5-HT(2A) receptor antagonists.
    McCort G; Hoornaert C; Aletru M; Denys C; Duclos O; Cadilhac C; Guilpain E; Dellac G; Janiak P; Galzin AM; Delahaye M; Guilbert F; O'Connor S
    Bioorg Med Chem; 2001 Aug; 9(8):2129-37. PubMed ID: 11504649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2-Substituted 5,6-dimethyl-3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidines: new series of highly potent and specific serotonin 5-HT6 receptor antagonists.
    Ivachtchenko AV; Golovina ES; Kadieva MG; Koryakova AG; Mitkin OD; Tkachenko SE; Kysil VM; Okun I
    Eur J Med Chem; 2011 Apr; 46(4):1189-97. PubMed ID: 21333408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New selective and potent 5-HT(1B/1D) antagonists: chemistry and pharmacological evaluation of N-piperazinylphenyl biphenylcarboxamides and biphenylsulfonamides.
    Liao Y; Böttcher H; Harting J; Greiner H; van Amsterdam C; Cremers T; Sundell S; März J; Rautenberg W; Wikström H
    J Med Chem; 2000 Feb; 43(3):517-25. PubMed ID: 10669578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Azabicyclic indole esters as potent 5-HT4 receptor antagonists.
    Wyman PA; Gaster LM; King FD; Sutton JM; Ellis ES; Wardle KA; Young TJ
    Bioorg Med Chem; 1996 Feb; 4(2):255-61. PubMed ID: 8814883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New arylpiperazine derivatives as antagonists of the human cloned 5-HT(4) receptor isoforms.
    Curtet S; Soulier JL; Zahradnik I; Giner M; Berque-Bestel I; Mialet J; Lezoualc'h F; Donzeau-Gouge P; Sicsic S; Fischmeister R; Langlois M
    J Med Chem; 2000 Oct; 43(20):3761-9. PubMed ID: 11020291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenyl benzenesulfonamides are novel and selective 5-HT6 antagonists: identification of N-(2,5-dibromo-3-fluorophenyl)-4-methoxy-3-piperazin-1-ylbenzenesulfonamide (SB-357134).
    Bromidge SM; Clarke SE; Gager T; Griffith K; Jeffrey P; Jennings AJ; Joiner GF; King FD; Lovell PJ; Moss SF; Newman H; Riley G; Rogers D; Routledge C; Serafinowska H; Smith DR
    Bioorg Med Chem Lett; 2001 Jan; 11(1):55-8. PubMed ID: 11140733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7/5-HT1A receptor selectivity.
    Medina RA; Sallander J; Benhamú B; Porras E; Campillo M; Pardo L; López-Rodríguez ML
    J Med Chem; 2009 Apr; 52(8):2384-92. PubMed ID: 19326916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1-[2-[(Heteroaryloxy)heteroaryl]carbamoyl]indolines: novel and selective 5-HT2C receptor inverse agonists with potential as antidepressant/anxiolytic agents.
    Bromidge SM; Dabbs S; Davies S; Duckworth DM; Forbes IT; Jones GE; Jones J; King FD; Saunders DV; Blackburn TP; Holland V; Kennett GA; Lightowler S; Middlemiss DN; Riley GJ; Trail B; Wood MD
    Bioorg Med Chem Lett; 2000 Aug; 10(16):1863-6. PubMed ID: 10969986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1,2,5-Thiadiazole derivatives are potent and selective ligands at human 5-HT1A receptors.
    Sabb AL; Vogel RL; Kelly MG; Palmer Y; Smith DL; Andree TH; Schechter LE
    Bioorg Med Chem Lett; 2001 Apr; 11(8):1069-71. PubMed ID: 11327592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and serotonergic activity of substituted 2, N-benzylcarboxamido-5-(2-ethyl-1-dioxoimidazolidinyl)-N, N-dimethyltryptamine derivatives: novel antagonists for the vascular 5-HT(1B)-like receptor.
    Moloney GP; Martin GR; Mathews N; Milne A; Hobbs H; Dodsworth S; Sang PY; Knight C; Williams M; Maxwell M; Glen RC
    J Med Chem; 1999 Jul; 42(14):2504-26. PubMed ID: 10411472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3,4-Dihydro-2H-benzo[1,4]oxazine derivatives as 5-HT6 receptor antagonists.
    Zhao SH; Berger J; Clark RD; Sethofer SG; Krauss NE; Brothers JM; Martin RS; Misner DL; Schwab D; Alexandrova L
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3504-7. PubMed ID: 17485206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Noncataleptogenic, centrally acting dopamine D-2 and serotonin 5-HT2 antagonists within a series of 3-substituted 1-(4-fluorophenyl)-1H-indoles.
    Perregaard J; Arnt J; Bøgesø KP; Hyttel J; Sánchez C
    J Med Chem; 1992 Mar; 35(6):1092-101. PubMed ID: 1348090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.